A Narrative Review of Microsporidial Infections of the Cornea.

Microsporidia are a rare and commonly misdiagnosed cause of corneal infection, accounting for approximately 0.4% of cases of microbial keratitis in some populations. Ocular microsporidiosis most often presents as either microsporidial keratoconjunctivitis (MKC) or microsporidial stromal keratitis (MSK). Though these two clinical entities exhibit similar symptomology, they are distinguished from one another by the time course for disease progression, findings on slit-lamp examination, and response to medical therapy. This review summarizes the current literature on the etiology and clinical presentation of microsporidial infections of the cornea and highlights ongoing developments in available diagnostic modalities and treatment regimens.

Key Summary Points

Introduction

Microsporidia are unicellular, obligate intracellular, eukaryotic parasites that belong to the phylum Microspora and subkingdom Protista [1, 2]. Microsporidia are true eukaryotes due to the presence of a nucleus with a nuclear envelope, chromosome separation on mitotic spindles, and an intracytoplasmic membrane system [3]. Unlike most eukaryotes, however, microsporidia lack typical mitochondria, peroxisomes, and centrioles. Moreover, they possess some “prokaryotic” characteristics such as tiny genomes, 70S ribosomes, and a fused 5.8S and 28S rRNA; for these reasons, they were once classified as protozoans, but are now considered closely related to fungi [4].

Since their discovery in 1857 in silkworms, over 1300 species of microsporidia belonging to nearly 200 genera have been described [5, 6]. Seven genera (Enterocytozoon species, Brachiola species, Encephalitozoon species, Pleistophora species, Nosema species, Vittaforma species, and Trachipleistophora species) as well as unclassified microsporidia, collectively referred to as Microsporidium, have been associated with human disease [7]. Microsporidia are opportunistic pathogens that have been implicated in infections of the intestines, eyes, sinuses, lungs, muscles, kidneys, and central nervous system [7]. Besides infections of the digestive tract, ocular disease is the second most common clinical manifestation of microsporidia [4]. In certain populations, microsporidia account for approximately 0.4% of cases of microbial keratitis [8]. The purpose of this review is to summarize the existing literature on the etiology, clinical presentation, diagnosis, and treatment of microsporidial infections of the cornea.

Methodology

A search of the literature was undertaken in October 2019 using PubMed without dates of exclusion. We included all English language papers related to microsporidial infections of the cornea. Foreign language articles were not included. The search terms used were microsporidiosis, stromal keratitis, ocular infection, keratoconjunctivitis, and various combinations of these terms. This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.

Pathophysiology

The characteristic feature of microsporidia is the intracellular spore, which confers resistance to adverse environmental conditions and promotes dissemination [9]. The spore length is typically between 2 and 8 µm but varies across species, ranging from 1 to 30 µm [10]. The cell wall of the spore is composed of a double envelope, of which the outer part contains glycoproteins and the inner part is primarily composed of chitin [11]. Within the endospore lies the sporoplasm, the infectious element formed by the cytoplasm and one or two nuclei [12]. Microsporidia infect host cells via an ejection apparatus known as the polar filament; different stimuli such as changes in pH, exposure to certain cations, or low-dose ultraviolet radiation can induce extrusion of the polar filament, which subsequently injects the sporoplasm into the cytoplasm of the host cell [13, 14]. Once inside the host cell, the sporoblast divides by binary fission to form schizonts with two to six nuclei. The schizonts split into unicellular meronts, which secrete a rigid capsule and attain the final size of 2.5 × 1.5 μm. The meronts further differentiate into sporonts and spores; when the cell eventually ruptures, these newly formed spores repeat the cycle to infect nearby host cells [15].

The mechanism by which microsporidial corneal infections occur remains unclear. Nonetheless, given that microsporidia are waterborne pathogens, direct inoculation through exposure to contaminated water in hot springs, rivers, and swimming pools has been implicated [16-18]. One retrospective case series found that 50% of patients had ocular exposure to muddy water [19]; another case series found that 47% endorsed a history of ocular trauma, though the degree of damage to the corneal epithelium was not noted [20]. Contact lenses may act as a vector by which the organism reaches the cornea; therefore, contact lens wear, especially in the setting of poor lens hygiene, is an important predisposing factor [21]. Microsporidial corneal infections have rarely arisen following ocular surgeries, including laser in situ keratomileusis (LASIK), Descemet stripping automated endothelial keratoplasty (DSAEK), penetrating keratoplasty (PK), and collagen cross-linking (CXL) [22-25]. A few outbreaks of ocular microsporidiosis in rugby players have been reported, likely secondary to exposure to contaminated soil on the playing field [26, 27]. Other risk factors include topical corticosteroid use, insect bites, and contact with domestic animals [4, 28, 29]. Most cases of microsporidial corneal infections have occurred in South and Southeast Asian countries; a higher incidence has been noted during the monsoon period from July to October, which is speculated to be related to contamination of water with microsporidia or an increase in the insect population [19, 30, 31].

Clinical Presentation

The first reported case of ocular microsporidiosis was in an 11-year-old Sri Lankan boy in 1973 by Ashton and Wirasinha [32]. Microsporidial corneal infections may present as an isolated infection or as part of systemic disease [33]. Though some case reports exist on scleritis [34] and endophthalmitis [35, 36] secondary to microsporidia, ocular microsporidiosis most often presents as one of two forms: superficial keratoconjunctivitis or stromal keratitis (Table 1).

Table 1

Characteristics of microsporidial keratoconjunctivitis and stromal keratitis

	Microsporidial keratoconjunctivitis (MKC)	Microsporidial stromal keratitis (MSK)
Risk factors	Exposure to contaminated water or soil [16–18, 26, 27], ocular trauma [20], contact lens wear [21], ocular surgeries [22–25], topical steroid use [4], insect bites [28], contact with domestic animals [29]
Time to presentation	Acute [42]	Delayed [3]
Clinical presentation	Photophobia, redness, tearing, foreign body sensation, impaired visual acuity, eye pain [4, 31, 42]
Slit-lamp findings	Grayish-white, coarse, multifocal, raised epithelial lesions and non-purulent conjunctivitis → central epithelial lesions → superficial punctate keratopathy → subepithelial infiltrates or haze [17]	Diffuse multifocal stromal infiltrates, non-purulent conjunctivitis, stromal edema, endothelial exudates; rarely, epithelial defects [20]
Differential diagnosis	Thygeson’s superficial punctate keratitis [44], Acanthamoeba keratitis [43], mycobacterial keratitis [21], adenoviral keratoconjunctivitis [40]	Fungal, bacterial, or HSV stromal keratitis [23]
Diagnostic techniques	Transmission electron microscopy (TEM) [4], light microscopy (LM) ± tissue staining [50], histopathology [4], polymerase chain reaction (PCR) [50], in vivo confocal microscopy (IVCM) [4, 6], anterior segment optical coherence tomography (AS-OCT) [4, 5]
Treatment options	Self-limiting [66]; most often treated with mono- or combination therapy consisting of topical fumagillin [7], oral albendazole [55], topical antibiotics [60], topical antifungals [62], and/or topical antiseptics [66]	Usually requires corneal graft transplantation [71], though some reports exist of resolution with medical therapy alone [20, 68–70]
Prognosis	Excellent [56]	Guarded [6, 8]

Microsporidial Keratoconjunctivitis

Throughout the 1990s, multiple cases of microsporidial keratoconjunctivitis (MKC) were diagnosed in individuals with immunosuppression secondary to acquired immunodeficiency syndrome (AIDS) [37-39]. Since then, numerous reports of MKC in healthy, immunocompetent adults have arisen over the past 2 decades [21, 40, 41]. The worldwide prevalence of MKC is on the rise due to increased awareness; nonetheless, most cases go undiagnosed or misdiagnosed as atypical adenoviral keratoconjunctivitis [42].

MKC most often occurs secondary to Encephalitozoon species and causes a self-limiting disease in immunocompetent patients [15]. Patients generally present with photophobia, redness, tearing, foreign body sensation, impaired visual acuity, and eye pain within 1 week of symptom onset [4, 31, 42]. A recent study by Wang et al. proposed that the pattern of lesions on slit-lamp examination may represent different stages of disease maturation [17]. The initial stage is characterized by a mild to severe non-purulent conjunctivitis and grayish-white, coarse, multifocal, raised epithelial lesions (Fig. 1). The resolution of peripheral lesions and conjunctivitis occurs within 1 week but is closely followed by the development of central epithelial lesions and superficial punctate keratopathy. Epithelial lesions resolve within 2 to 4 weeks, after which subepithelial infiltrates or haze may form (Fig. 2). Notably, not all stages are seen in every patient, but the natural progression follows the above pattern [17]. Rarely, mucopurulent discharge and regional lymph node involvement may be seen [18].

Fig. 1

Microsporidial keratoconjunctivitis

(Photo from Dr. Nikhil S. Gokhale)

Fig. 2

Microsporidial keratoconjunctivitis

(Photo from Dr. Ladan Espandar)

Microsporidial Stromal Keratitis

Microsporidial stromal keratitis (MSK) is rarer than superficial keratoconjunctivitis and occurs predominantly in immunocompetent individuals. MSK follows a slow-growing, insidious course, with symptoms ranging from 1 month to 2 years prior to the initial presentation [3]. MSK typically occurs secondary to Vittaforma corneae (previously Nosema corneum) or Microsporidium [15, 43]. MSK manifests symptomatically as unilateral ocular pain, conjunctival redness, photophobia, impaired visual acuity, and foreign body sensation. Slit-lamp biomicroscopy of MSK most often reveals diffuse multifocal mid- to deep stromal infiltrates with mild to moderate conjunctival injection, stromal edema, and endothelial exudates. The overlying epithelium is typically intact, though rarely epithelial defects may be visible over the stromal lesions (Fig. 3) [20].

Fig. 3

Microsporidial stromal keratitis

(Photo from Dr. Nikhil S. Gokhale)

Differential Diagnosis

Due to the rarity of microsporidia as a cause of corneal infection and the lack of characteristic clinical examination findings, both MKC and MSK are frequently misdiagnosed. Namely, the multifocal epitheliopathy seen in MKC may be confused for Thygeson’s superficial punctate keratitis [44], Acanthamoeba keratitis [43], mycobacterial keratitis [21], or viral keratoconjunctivitis [40]; however, the multifocal, coarse, raised epithelial infiltrates seen in MKC are a key distinguishing feature from the above listed clinical entities. Furthermore, subepithelial lesions seen in MKC are larger than the nummular infiltrates present in viral keratoconjunctivitis [45]. In contrast to MKC, adenoviral keratoconjunctivitis is often characterized by an increased number of dendritic cells in the central cornea due to the activation of the innate immune system [46].

MSK may closely resemble fungal, bacterial, or HSV keratitis, leading to further delays in diagnosis [23]. Rarely, MSK may be mistaken for Acanthamoeba keratitis [47]. One case series of 34 patients with MSK found that 38.2% and 32.3% of patients were initially diagnosed with HSV stromal keratitis and fungal keratitis, respectively. Consequently, the mean duration between the initial presentation and final diagnosis in this study was 94.0 ± 232.2 days [20]. The major clues towards a diagnosis of MSK are an unsatisfactory initial response to corticosteroids and characteristic appearance of the stromal infiltrate that does not resemble bacterial or fungal infections. Moreover, patients with MSK are unlikely to present with deep vascularization with stromal scarring, a common feature in HSV stromal keratitis [20].

Ultimately, microsporidia are best identified through an examination of morphologic features in tissue studies; thus, the clinician must have a high index of suspicion to include microsporidia in the differential [15].

Diagnosis

Microsporidia are often difficult to detect since they are obligate intracellular organisms and require specific cell culture systems for growth [46]. The diagnosis of microsporidial corneal infections most often hinges on morphologic identification of organisms on tissue scrapings; however, due to their small size, microsporidia may still evade detection on microscopy. Therefore, several molecular and non-invasive techniques may aid in the diagnosis.

Transmission Electron Microscopy

Transmission electron microscopy (TEM) was long regarded as the gold standard for the identification of microsporidia. Organisms may be definitively classified as a member of the phylum Microspora by the presence of a polar tubule on TEM. TEM is further capable of differentiating species based on their ultrastructural characteristics. Vittaforma corneae, which most often causes MSK but has been implicated in some cases of MKC, is identified by a spore size of 3–5 µm and 11–13 coils in the polar tubule. Conversely, Encephalitozoon species, which typically cause MKC, are identified by 2–3 µm spores and contain 4–7 coils in the polar tubule; moreover, they are characterized by the presence of a parasitophorous vacuole surrounding the organism in the host cell [15]. The identification of specific Microsporidia species may be useful for tailoring treatment regimens and determining prognosis. However, TEM is not often used as an initial screening tool in the modern era as it is time-consuming, not routinely available, and carries a lower relative sensitivity due to the small amount of tissue that can be examined [4].

Light Microscopy

Light microscopy is the most common technique for the detection of microsporidia in the modern era. Alcohol-fixed cytologic samples have proven useful for the detection of microsporidial blastospores [48]. Various stains are available that may increase the sensitivity of microscopic examination. On Weber’s modified trichrome stain, microsporidia spore walls appear bright pinkish-red against a blue or faint green background, sometimes with a belt-like stripe that encircles the spores equatorially or diagonally [49]. Gram stain may be useful for identification of mature spores but should only be used on specimens with little debris to reduce potential false positives (Fig. 4). Giemsa stain carries the advantage of making the nuclei visible and revealing developmental stages; however, it has low sensitivity and is not recommended for routine use [4]. Modified Ziehl-Neelsen (acid-fast) stain is highly sensitive, but not always readily available in many clinical practices (Fig. 5). A study by Joseph et al. determined a sensitivity of 90.3% with gram stain, 64.5% with Giemsa stain, and 87% with modified acid-fast stain for the detection of microsporidia [50]. Chitin in the cell wall of spores appears bright when stained with fluorescent agents such as calcofluor white, Uvitex 2B, or Fungi-Fluor. These agents are rapid and sensitive, though many other structures such as fungal spores may give false-positive results [51]. The sensitivity of potassium hydroxide with calcofluor white was found in one study to be 93.5% [50]. The major drawback of light microscopy as a diagnostic technique is that the interpretation of slides is time-consuming, requires an experienced observer, and does not allow for the identification of specific species.

Fig. 4

Microsporidial spores are seen as clusters of unstained halos in gram stain of the corneal scraping (black arrow)

(Photo from Dr. Jyoti Prakash Panda. Gram’s, × 100)

Fig. 5

Modified Ziehl-Nielsen stain of microsporidia. Oval reddish-pink microsporidia are present (black arrow)

(Photo from Dr. Jyoti Prakash Panda. 1% Acid-fast, modified ZN, ×100)

Histopathology

Routine histopathology is occasionally attempted in the detection of microsporidia. Modified trichrome, modified Ziehl-Neelsen, and modified gram stains are generally sensitive and recommended for this purpose. Detection of microsporidia on hematoxylin and eosin (H&E) and Giemsa stains is largely dependent on the experience of the pathologist and carries variable accuracy if there are a low number of parasites in the specimen [4].

Some immunofluorescent antibody techniques have been developed for the detection of Encephalitozoon species spores, though they are less convenient compared with traditional chromotrope and fluorochromes. Moreover, reagents for immunofluorescence staining of microsporidial spores may have low specificity because of background staining and cross-reactions with yeast and bacteria [3]. Lastly, these techniques are not yet readily available in many laboratory settings.

Polymerase Chain Reaction

Molecular identification is a rapid, low-cost diagnostic technique that allows for the identification of most species implicated in ocular infections. Polymerase chain reaction (PCR) most often uses small-subunit rRNA sequences for species-specific detection [7, 50]. Two different PCR primers for detection of microsporidia have been described in the literature: a PCR-1 primer with a DNA fragment length of 1150 bp [52], and a PCR-2 primer with a DNA fragment length of 250 bp [53]. The PCR-2 primer was demonstrated by Joseph et al. to carry a sensitivity and specificity of 83% and 98%, respectively [50]. Wang et al. found the PCR-2 primer to be more sensitive than the PCR-1 primer; these authors hypothesized that as a result of the longer DNA fragment length, there may be an increased number of replication errors introduced by Taq polymerase [17]. Another novel technique described by Polley et al. used the SYBR Green real-time PCR assay to identify individual Microsporidia species [54]. Though advancements in PCR technology continue to emerge, PCR alone should not be used for the detection of microsporidia because of a lower relative sensitivity than other described techniques.

Non-Invasive Techniques

All diagnostic procedures described thus far rely upon corneal scraping or biopsy, which unavoidably creates an epithelial defect. Although rare, corneal scraping may result in significant corneal abrasions, which subsequently cause patient discomfort and delay visual rehabilitation [45]. Of more serious concern is that the process of scraping corneal tissue may facilitate deeper penetration, converting potentially self-limiting keratoconjunctivitis to treatment-resistant stromal keratitis. Furthermore, the accuracy of the above techniques largely depends on the amount and distribution of organisms obtained from the corneal scraping, the staining process, and the diagnostic skills of the observer [43]. In vivo confocal microscopy (IVCM) and anterior segment optical coherence tomography (AS-OCT) are two novel diagnostic methods that preclude the need for corneal scrapings.

IVCM relies upon the Heidelberg Retina Tomograph (HRT II), a 670-nm wavelength diode laser, to produce in vivo images of the anterior segment. IVCM of MKC reveals multiple rosette-like clusters of epithelial cells in which spores are visualized as hyperreflective, pinpoint oval intracellular bodies [46]. In stromal keratitis, spores tend to align along lamellae [55]. The absence of a significantly increased number of dendritic cells in the deeper epithelial layers is particularly helpful in distinguishing microsporidial keratoconjunctivitis from adenoviral infection [46]. IVCM is also useful for monitoring response to medical therapy [55]. The specificity and sensitivity of IVCM in detecting microsporidia has not been reported in the literature; nonetheless, some authors have recommended that IVCM be adopted as a first-line screening tool [46].

AS-OCT is a non-invasive, high-resolution technique that uses a 1050-nm wavelength light source to scan the entire cornea with a radial pattern within one frame (Fig. 6). A single prospective study found that all 13 patients with MKC exhibited hyperreflective dots limited to the epithelial layers of the cornea on AS-OCT. AS-OCT is especially useful for distinguishing MKC from viral keratoconjunctivitis, which is more likely to present with a smooth epithelial surface and hyperreflective lesions in the subepithelial layer that extend to the anterior stroma. The authors of this study concluded that although AS-OCT could not serve as the gold standard for diagnosis, it may guide treatment, especially in conditions in which corneal scraping is not otherwise possible [45].

Fig. 6

Anterior segment optical coherence tomography demonstrating stromal haze involving the anterior half of the cornea with normal epithelial integrity

(Photo from Dr. Ladan Espandar)

Treatment/Management

MKC

There remains no consensus on medical treatment for MKC; as such, various therapeutic regimens have been attempted. Response to medical therapy is highly dependent upon the species involved and the immune status of the patient [9]. In most case, the visual prognosis is good with no loss of visual acuity after MKC resolution [56].

Of all available medications, fumagillin and albendazole have demonstrated the most antimicrosporidial activity in vitro [57]. Fumagillin is a water-insoluble antibiotic that has been used extensively. The mechanism of action of fumagillin is not entirely understood, but it is believed to alter DNA content or inhibit RNA synthesis in the organism [15]. One study found that topical fumagillin bicylohexylammonium (Fumidil B) 3 mg/ml, equivalent to 70 µg/ml fumagillin, used topically every hour during daytime for 7 days allowed MKC symptoms to subside; however, because fumagillin is parasitistatic rather than parasiticidal, symptoms may return upon discontinuation of topical Fumidil B [7]. Albendazole is a broad-spectrum antihelminthic that inhibits microtubule formation and has shown clinical efficacy in the treatment of microsporidial corneal infections [2, 58]. Albendazole is most commonly prescribed as 400 mg oral tablets to be taken once or twice daily as monotherapy or in combination with fumagillin [55]. Of note, albendazole may have limited efficacy against certain species of microsporidia such as Enterocytozoon bieneusi, reinforcing the importance of designing a species-specific treatment regimen [35, 59].

Several other treatment regimens have been described. Topical fluoroquinolone monotherapy (moxifloxacin 0.5%, ciprofloxacin 0.3%, norfloxacin 0.3%, etc.) six or more times daily has resulted in sustained symptom resolution without disease recurrence [45, 60]. One study of 134 eyes found complete symptom resolution in 99% of patients on fluoroquinolone monotherapy [19]. Other studies have used a combination of topical fluoroquinolones with topical voriconazole 1% six times daily [46], 0.1% betamethasone 0.1% twice daily [17], topical propamidine isethionate 0.1% every hour [27], or oral albendazole 400 mg twice daily [25]. Alternatively, some physicians prefer topical fluconazole 0.3% six times daily as monotherapy or in combination with 0.3% ciprofloxacin ointment [29, 42, 61]. Khandelwal et al. found that topical voriconazole 1% monotherapy every 2 h led to complete resolution of MKC in two patients [62]. Topical propamidine isethionate 0.1% six times daily monotherapy and oral itraconazole 100 mg twice daily monotherapy have previously been described, though these regimens do not appear to be commonly employed in the modern era [39, 63–65]. Regardless of which antimicrobial therapy is elected, treatment is generally tapered with clinical improvement over several weeks to months.

Notably, there is some question as to whether antimicrobial therapy or debridement is necessary given the self-limiting nature of MKC. A randomized controlled trial by Das et al. found no significant difference in time to resolution between patients with MKC who were treated with polyhexamethylene biguanide (PHMB) 0.02% every 4 h or placebo [66]. Another study found that all patients with MKC who underwent debridement achieved resolution without recurrence regardless of the medication regimen, suggesting that debridement of the epithelium plays the most significant role in treatment [8]. Conversely, a randomized clinical trial found no significant difference in the final visual outcome and resolution time between patients who underwent debridement and those who did not; notably, none of the patients in this study received antimicrobial therapy [67]. There is some evidence to suggest that repeat corneal swabbing without the use of debridement is sufficient to eradicate epithelial microsporidial lesions [44]. Debridement increases the risk that pathogens may penetrate the deep stromal layers and convert a self-limiting MKC to a treatment-resistant MSK; as such, some authors advise that if debridement is performed, it should be accompanied by prophylactic topical antimicrobials to prevent subsequent microsporidial or bacterial growth [27, 44].

Most authors do not recommend the use of topical corticosteroids as this may allow for persistent infection due to the promotion of a local immunocompromised state [40]; however, some feel that steroids are warranted to prevent the subsequent formation of nummular keratitis, stromal haze, or uveitis [17]. Agashe et al. found in their retrospective case series of 550 patients with MKC that 10.1% developed nummular keratitis and 1% developed uveitis; in these cases, tapered treatment with topical steroids (fluorometholone 0.1% or prednisolone acetate 1%) is warranted until complete resolution of the infection is achieved [16].

MSK

MSK carries a poor prognosis and tends to be resistant to medical therapy [68], though a few cases exist of successful treatment with a combination of topical and systemic antimicrobials. Sangit, Murthy, and Garg were the first to describe a case of MSK that was responsive to medical therapy; a combination of 0.02% topical chlorhexidine gluconate hourly and 400 mg oral albendazole twice daily given for 12 weeks resulted in complete resolution in a 14-year-old girl [69]. Another case report described the resolution of MSK following dual therapy of topical voriconazole 1% daily and oral itraconazole 200 mg twice daily for 8 weeks [68]. Five patients in a case series by Sabhapandit et al. responded to combination therapy with PHMB 0.02% and chlorhexidine 0.02% every half to 1 hour and oral albendazole 400 mg twice daily [20]. The most recent report by Grillo et al. found that MSK subsided following albendazole 400 mg once daily over 2 weeks and topical voriconazole 1% and fumagillin 3 mg/ml eye drops over 10 weeks [70].

Though these initial findings are intriguing, most reported cases of MSK have gone on to require surgical excision of tissue with corneal graft transplantation [71]. Most authors recommend PK over lamellar keratoplasty to avoid any chance of recurrence in the lamellar bed [68]. Notably, Ang et al. described a case in which deep anterior lamellar keratoplasty (DALK) allowed for visual rehabilitation in a woman with severe MSK [72]. However, Sabhapandit et al. found that all patients who underwent DALK in their case series experienced MSK recurrence and required PK at a later time [20]. Overall, PK remains the gold standard for the treatment of MSK, but greater insight into the ideal treatment regimen will emerge as MSK becomes more frequently recognized.

Conclusion

Microsporidia are a rare cause of corneal infections that most often present as acute superficial keratoconjunctivitis secondary to Vittaforma corneae or slow-growing, recalcitrant stromal keratitis secondary to Encephalitozoon species. Though ocular microscopy and tissue staining remain the most common tools for the detection of Microsporidia, molecular and non-invasive techniques may play an expanding role in the diagnosis. The ideal treatment regimen for microsporidial corneal infections remains unclear, especially given the self-limiting nature of MKC. Topical fumagillin and oral albendazole are among the most commonly used antimicrobials, but a variety of regimens have been described. A few cases of MSK have responded to medical therapy, but the majority of patients require corneal graft transplantation. As physicians become more aware of microsporidia as a potential cause for corneal infection, new insights into the optimal therapeutic regimen will continue to arise.

Microsporidia are unicellular, eukaryotic parasites that may rarely cause ocular infections, most often following ocular trauma or exposure to contaminated water.

Ocular microsporidiosis typically presents as either acute keratoconjunctivitis or insidious stromal keratitis.

The coarse, multifocal, raised epithelial infiltrates seen on slit-lamp examination of microsporidial keratoconjunctivitis are a key distinguishing feature from other more common causes of ocular infection.

Light microscopy of tissue scrapings is the most common technique for the diagnosis of ocular microsporidiosis in the modern era.

Various pharmacotherapy regimens have been described as effective in treating microsporidial keratoconjunctivitis; conversely, microsporidial stromal keratitis is typically resistant to antimicrobial therapy and most often requires surgical excision of affected tissue with corneal graft transplantation.